1080-07-5

Usage

Uses

Used in Pharmaceutical Research:
3-Bromo-4-methoxycinnamic acid is used as a key intermediate in the development of pharmaceuticals for its potential antimicrobial and antioxidant properties. It contributes to the creation of new drugs that can combat various diseases and conditions by inhibiting the growth of harmful microorganisms and neutralizing harmful free radicals.
Used in Agrochemical Development:
In the agrochemical industry, 3-Bromo-4-methoxycinnamic acid is utilized as a component in the synthesis of pesticides and other crop protection agents. Its antimicrobial properties make it a valuable asset in developing products that protect crops from diseases and pests, thereby ensuring higher yields and better quality produce.
Used in Materials Science:
3-Bromo-4-methoxycinnamic acid is employed as a building block in materials science for the synthesis of new materials with unique properties. Its versatility allows it to be incorporated into the development of advanced materials for various applications, such as sensors, catalysts, and other specialized materials that can improve the performance of various products and technologies.
Used in Organic Synthesis:
As a key component in organic synthesis, 3-Bromo-4-methoxycinnamic acid is used as a starting material or a reactant in the synthesis of a wide range of organic compounds. Its reactivity and functional groups make it suitable for various chemical reactions, enabling the production of complex molecules with specific properties and applications.
To ensure the stability and purity of 3-Bromo-4-methoxycinnamic acid, it is typically handled and stored under specific conditions, which may include low temperatures, dry environments, and protection from light exposure. This careful handling ensures that the compound maintains its integrity and effectiveness in its various applications.

Upstream product

• 34841-06-0 3-bromo-4-methoxybenzylaldehyde 
• 141-82-2 malonic acid 
• 123-11-5 4-methoxy-benzaldehyde 

Downstream Products

• 1092300-08-7 C₁₀H₈BrClO₂ 
• 151539-48-9 (E)-8-(3-Bromo-4-methoxystyryl)-1,3-dipropylxanthine 
• 888738-40-7 methyl (E)-3-(3-bromo-4-methoxyphenyl)acrylate 
• 1445564-64-6 (6-bromo-7-methoxyisoquinolin-1-yl)tritylamine 
• 1445564-56-6 C₁₀H₈BrN₃O₂ 

Relevant academic research and scientific papers

Concise total synthesis of aplysinellamides A and B

Concise and efficient total syntheses of bromotyrosine-derived metabolites aplysinellamides A and B, isolated from Australian marine sponge Aplysinella sp., have been accomplished in seven steps. A condensation between cinnamic acid and Boc-D-lysine methyl ester was applied to form the amide skeleton as a key step.

ANTI-HIV COMPOUNDS

This invention provides, among other things, tetrahydroisoquinolines useful for treating viral infections, pharmaceutical formulations containing such compounds, as well as methods of inhibiting the replication of a virus, such as HIV, or treating a disease, such as AIDS.

SULPHONYLAMINOPYRROLIDINONE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION

The invention relates to new sulphonylaminopyrrolidinone compounds having antithrombotic activity which, in particular, inhibit blood clotting factor IXa and/ or factor Xa, to processes for their preparation and to use thereof as drugs.

The first total synthesis of aplysamine 6, an inhibitor of isoprenylcysteine carboxy methyltransferase

The first total synthesis of aplysamine 6, an inhibitor of isoprenylcysteine carboxy methyltransferase (Icmt), was accomplished in an overall high yielding reaction sequence.

NOVEL BICYCLIC AROMATIC COMPOUNDS, THE PRODUCTION AND USE THEREOF IN THE FORM OF DRUGS

The invention relates to novel aromatic bicycle compounds of formula (I), wherein Ar, X, Y and R1-R3 are such as specified in a claim 1. Said invention also relates to the tautomers, enantiomers, diasteriomers, mixtures, pro-drugs an